Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07196917 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 1 to 2
    • Eligibility criteria expanded, about 1 word
    • Secondary endpoints expanded, about 2 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To further explore the application prospects of integrated Traditional Chinese and Western medicine in chronic disease prevention and control and health management, this study intends to establish a large, prospective, integrated Traditional Chinese and Western medicine cohort in Hubei Province. This study will conduct long-term follow-up and multi-dimensional data collection to systematically reveal the associations between Traditional Chinese Medicine (TCM) constitution types and chronic diseases, the aging process, and multi-morbidity, thereby developing an integrated health management strategy with local characteristics. This study will fill the current gap in systematic evidence linking TCM constitutions to the prevalence of modern diseases, providing a solid demographic and biological foundation for the integrated development of Traditional Chinese and Western medicine. It will also contribute to meeting the needs for early disease warning, early intervention, and personalized care under the "Healthy China" strategic goal.
Trial Details
NCT Number NCT07196917
Lead Sponsor Huazhong University of Science and Technology
Collaborators: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei College of Traditional Chinese Medicine, Hubei Hospital of Traditional Chinese Medicine, Hubei Provincial Center for Disease Control and Prevention, Wuhan Center for Disease Control and Prevention
Conditions
(from sponsor)		 Cardiovascular Diseases, Respiratory Tract Diseases, Cancer, Endocrine System Diseases, Death
Related terms Cardiovascular Diseases, Death, Endocrine System Diseases, Neoplasms, Respiratory Tract Diseases
Enrollment 1,000,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov